FACT II Acquisition
FACTU · NASDAQ
About FACTU
- Employees
- 0
- Headquarters
- New York City, New York
- Listed
- Nov 26, 2024
- Sector
- N/A
- Industry
- N/A
FACTU key statistics
- Market cap
- 261.70M
- Price-earnings ratio
- 0.00
- Dividend yield
- —
- Average volume
- 24
- Volume
- 536
- Open price
- $10.80
- High today
- $10.80
- Low today
- $10.80
- 52 Week high
- $15.00
- 52 Week low
- $10.45
FACT II Acquisition (FACTU) at a glance
FACT II Acquisition (FACTU) last traded at $10.80, with a market cap of 261.70M and a price-to-earnings ratio of 0.00.
Volume so far is 536 shares, above the average of 24 shares a day.
Over the past year FACT II Acquisition has ranged from $10.45 to $15.00, and now sits 8% of the way up that range.
FACTU news
- Press releaseBusiness Wire
- Press releaseBusiness Wire
Precision Aerospace & Defense Group Reschedules Investor Day to March 12, 2026
- Press releaseBusiness Wire
Precision Aerospace & Defense Group to Host Investor Day on February 25, 2026
Most active stocks
Highest trading volume today
- RDARRaadr$0.0002+0.00%
- DVLTDatavault AI$0.0879+31.19%
- RCTRedCloud Holdings$0.0617−5.95%
- TIPSTianrong Internet Products & Services$0.0014+27.27%
- GTVHGolden Triangle Ventures$0.0002+0.00%
- AITXArtificial Intelligence Technology Solutions$0.0005−43.75%
- CDTCDT Equity$0.083+3.75%
- EARIEntertainment Arts Research$0.0002+0.00%
- NBNDNetBrands$0.0006−14.29%
- NVDGraniteShares ETF Trust$4.01+2.04%
- STLAStellantis N.V$4.68+13.04%
- NTRRNeutra$0.0002+0.00%
Newly listed
Companies that went public in the past six weeks
- SCQCUSPACCircle Acquisition$9.97−0.05%
- LYCALycia Therapeutics$25.05−4.06%
- DAVIDAVION HEALTHCARE$3.29+9.67%
- TCXBTCGX Acquisition Corp. II$10.27−0.10%
- CTYCITY THERAPEUTICS$21.65+3.79%
- IAMIambic Therapeutics$14.78+5.57%
- AMROAmaero$5.86−2.98%
- FLSCFrazier Life Sciences Acquisition Corp. II$10.23−0.49%
- TRXBTRex Bio$14.43+4.64%
- RTSNRetension Pharmaceuticals$13.09−3.18%
- PAXGUPine Tree Acquisition$10.02+0.20%
- PORTUSouthport Acquisition Corp. IIListed Oct 1, 2026
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.